the behavioral testing protocol has been described previously in detail (Wright et al., 1999)
In a new user, active comparator study design using data available in the electronic health record, adults with T2DM and comorbid asthma who initiated a GLP-1Ra for treatment intensification for T2DM experienced the lowest risk of asthma exacerbation in the following 6 months compared to those initiating sulfonylureas, SGLT-2i, or DPP-4 inhibitors [113]
2026 Feb;44(1):187-202
How GLP-1 Therapy Restores What Your Body Isn't Making Semaglutide, the active compound in PlexusDx injectable therapy, mimics the GLP-1 your intestines produce naturally but delivers a consistent, therapeutic dose your body cannot generate on its own
Based on the current safety data, experts encourage people to think carefully about whether glutathione injections are worth the risk
Worst case - If side effects get severe, you must inform your prescriber immediately